US Alzheimer’s Disease Market Analysis and Competitive Landscape Highlights – 2020, provides comprehensive insights into Alzheimer’s Disease pipeline products, Alzheimer’s Disease epidemiology, Alzheimer’s Disease market valuations and forecast, Alzheimer’s Disease drugs sales and competitive landscape in the US.
Research Scope:
– Alzheimer’s Disease Pipeline: Drugs in clinical trials for the treatment of Alzheimer’s Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
– Alzheimer’s Disease Epidemiology: Number of patients diagnosed (prevalence) with Alzheimer’s Disease in the US
– Drugs sales: Sales revenues for Alzheimer’s Disease drugs in the US
– Market valuations: US Alzheimer’s Disease market size for in 2019; find out how the market advanced from 2016 and forecast to 2025
– Drugs market share: Market shares for key Alzheimer’s Disease drugs in the US
This research helps executives to
– Support monitoring and reporting national Alzheimer’s Disease market analysis and sales trends
– Track competitor drugs sales and market share in the US Alzheimer’s Disease market
– Track competitive developments in Alzheimer’s Disease market and present key issues and learnings
– Synthesize insights for Alzheimer’s Disease market and products to drive business performance
– Answer key business questions about the Alzheimer’s Disease market
– Evaluate commercial market opportunity assessment, positioning, and segmentation for Alzheimer’s Disease products
– Supports decision making in R&D to long term marketing strategies
Table of Contents
1) Alzheimer’s Disease Treatments
2) Alzheimer’s Disease Drugs Pipeline
3) US Alzheimer’s Disease Epidemiology
4) Marketed Drugs for Alzheimer’s Disease in the US
5) Alzheimer’s Disease Market Size and Forecast
6) Alzheimer’s Disease Drugs Sales and Forecast
7) Alzheimer’s Disease Market Competitive Landscape
8) Methodology
9) Contact us
List of Tables
1. Alzheimer’s Disease Phase 3 Clinical Trials, 2020
2. Alzheimer’s Disease Phase 2 Clinical Trials, 2020
3. Alzheimer’s Disease Phase 1 Clinical Trials, 2020
4. Alzheimer’s Disease Epidemiology, US, 2016 – 2025
5. Marketed Drugs for Alzheimer’s Disease, US, 2019
6. Alzheimer’s Disease Market Size and Forecast ($mn), US, 2016 – 2025
7. Alzheimer’s Disease Drugs Sales ($mn), US, 2016 – 2025
List of Figures
1. Alzheimer’s Disease Epidemiology, US, 2016 – 2025
2. Alzheimer’s Disease Market Size and Forecast ($mn), US, 2016 – 2025
3. Alzheimer’s Disease Drugs Market Share (%), US, 2019
Format
Dispatch format is XLSX.